QIANG Guang-liang, QIAN Kun, DAI Tian-yang, HE Hua-yu. Debate of Exploration of Adjuvant Therapy Mode for Postoperative ⅠB~ⅢA EGFR Mutated NSCLC[J]. Journal of Evidence-Based Medicine, 2024, 24(4): 222-226. DOI: 10.12019/j.issn.1671-5144.202406013
Citation:
|
QIANG Guang-liang, QIAN Kun, DAI Tian-yang, HE Hua-yu. Debate of Exploration of Adjuvant Therapy Mode for Postoperative ⅠB~ⅢA EGFR Mutated NSCLC[J]. Journal of Evidence-Based Medicine, 2024, 24(4): 222-226. DOI: 10.12019/j.issn.1671-5144.202406013
|
QIANG Guang-liang, QIAN Kun, DAI Tian-yang, HE Hua-yu. Debate of Exploration of Adjuvant Therapy Mode for Postoperative ⅠB~ⅢA EGFR Mutated NSCLC[J]. Journal of Evidence-Based Medicine, 2024, 24(4): 222-226. DOI: 10.12019/j.issn.1671-5144.202406013
Citation:
|
QIANG Guang-liang, QIAN Kun, DAI Tian-yang, HE Hua-yu. Debate of Exploration of Adjuvant Therapy Mode for Postoperative ⅠB~ⅢA EGFR Mutated NSCLC[J]. Journal of Evidence-Based Medicine, 2024, 24(4): 222-226. DOI: 10.12019/j.issn.1671-5144.202406013
|